Surmodics, Inc. (NASDAQ:SRDX) Files An 8-K Other EventsItem 8.01 Other Events.
99.1Press Release dated July26, 2017
SURMODICS INC ExhibitEX-99.1 2 a51596578ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 Surmodics Receives IDE Approval to Initiate Pivotal Trial of the SurVeil™ Drug-Coated Balloon Study compares SurVeil™ DCB to Medtronic IN.PACT® Admiral® DCB SurVeil DCB design includes new proprietary coating for interventional treatment of PAD EDEN PRAIRIE,…To view the full exhibit click here
About Surmodics, Inc. (NASDAQ:SRDX)
Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company’s Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company’s In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.
